This study aims to systematically review randomized clinical trials (RCTs) evaluated the effects of resveratrol on vascular flow-mediated dilation (FMD).
All published RCTs in English were systematically searched on PubMed and Scopus search engines up to October 2017. A total of 61 studies were found through search databases. The outcome variable of interest was FMD. Six articles which met inclusion criteria were included in this study.
From six studies, four showed a significant improvement in FMD after resveratrol supplementation acutely or chronically in subjects with cardio-metabolic risk factors. Two other studies did not show any significant effect of resveratrol on FMD.
The authors systematically reviewed the effectiveness of resveratrol supplementation on FMD for the first time. The findings suggest that pure resveratrol supplementation may have beneficial effects on endothelium dependent vasodilatation indicator, FMD.
This study is related to the project NO. 1396/66156 from Student Research Committee, Shahid Beheshti University of Medical Sciences (SBMU), Tehran, Iran. The authors also appreciate the Student Research Committee and Research and Technology Chancellor at SBMU for the financial support of this study.
Disclosure statement: None of the authors had any personal or financial conflicts of interest.
Funding: This study is related to the project NO. 1396/66156 from Student Research Committee, Shahid Beheshti University of Medical Sciences (SBMU), Tehran, Iran.
Emamat, H., Djafarian, K., Tangestani, H., Hekmatdoost, A. and Shab-Bidar, S. (2019), "Resveratrol supplementation and flow-mediated dilation: a systematic review", Nutrition & Food Science, Vol. 49 No. 4, pp. 580-591. https://doi.org/10.1108/NFS-08-2018-0245
Emerald Publishing Limited
Copyright © 2018, Emerald Publishing Limited